Fertility becomes big business as NHS cuts back on treatment
By Sarah Boseley,
The Guardian (UK)
| 11. 06. 2010
[United Kingdom]
Nicosia looks nice. The clinic website shows pictures of boats bobbing on blue-green Cypriot waters. Spain feels more familiar, but the Ukraine is cheaper. Or what about Mexico, where you can choose whether to have a boy or a girl?
The fertility business is global and booming. As the NHS cuts back on free treatment for the childless, lumping IVF with tattoo removal as an act of kindness rather than treatment for a disease, the competitive prices of private clinics overseas compared with their UK rivals will look ever more tempting. This weekend a number of them will be touting for business at the Fertility Show, now in its second year, at London's Olympia.
Their websites are in English, their blandishments are soothing and the success rates they advertise are eye-popping to those unversed in the complexities of such data. You can get an instant email quote (in sterling) – I was offered IVF using donor eggs (difficult to obtain in the UK) in Kiev for £5,277, in Nicosia for £3,945 (including six days in a hotel and airport transfer)...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
